0

diabetes coronary artery disease pathophysiology

Báo cáo y học:

Báo cáo y học: "Two-year Outcome of Turkish Patients Treated with Zotarolimus Versus Paclitaxel Eluting Stents in an Unselected Population with Coronary Artery Disease in the Real World: A Prospective Non-randomized Registry in Southern Turk

Y học thưởng thức

... Abbreviations: Cx, left circumflex coronary artery; LAD, left ante-rior descending coronary artery; LVEF, left ventricular ejection fraction; RCA, right coronary artery. aIndicates patients who ... J. Med. Sci. 2011, 8 http://www.medsci.org 69 (BMSs) in patients with symptomatic coronary artery disease of simple to moderate complexity (1-3). The use of the Zotarolimus-eluting stent ... 14. Ellis SG, Vandormael MG, Cowley MJ. Coronary morphologic and clinical determinants of procedural outcome with angiop-lasty for multivessel coronary disease: implications for patient selection....
  • 6
  • 550
  • 0
Báo cáo y học:

Báo cáo y học: "Efficacy of Sirolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease: 24-Month Outcomes of Patients in a Prospective Non-randomized Registry in Southern Turkey&

Y học thưởng thức

... Abbreviations: Cx, left circumflex coronary artery; LAD, left anterior descending coronary artery; LVEF, left ventricular ejection fraction; RCA, right coronary artery. aIndicates patients who ... better long-term safety and efficacy than the PES in unselected Turkish patients with coronary artery disease. However, despite our study and several others in which the SES and the PES have ... C, Mann JT, Turco M, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231 3. Valgimigli M, van Mieghem CA, Ong AT, Aoki J,...
  • 6
  • 627
  • 0
Coronary Artery Disease – New Insights and Novel Approaches Edited by Angelo Squeri pdf

Coronary Artery Disease – New Insights and Novel Approaches Edited by Angelo Squeri pdf

Sức khỏe giới tính

... 1 Pathogenesis Coronary Artery Disease – New Insights and Novel Approaches 283.6 Gene-gene and gene-environmental interaction in manifestation of coronary artery disease The fact that ... influencing various aspects of coronary artery function and structure with prevalent genetic factors. Coronary Artery Disease – New Insights and Novel Approaches 26the disease. Plasma leptin ... surrounding network with blood supply. 2. What causes coronary artery disease? Since coronary arteries deliver blood to the heart muscle, disease can have serious implications by reducing the...
  • 270
  • 931
  • 0
báo cáo hóa học:

báo cáo hóa học:" Static platelet adhesion, flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over study" potx

Hóa học - Dầu khí

... TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over studyAndreas C Eriksson*1, Lena Jonasson2, Tomas L ... http://www.translational-medicine.com/content/7/1/42Page 7 of 14(page number not for citation purposes)Comparisons between patients with coronary artery disease and controlsThe factors were further analysed by One-sample t-test fordifferences ... controls at two separateoccasions (Figure 2).Effects of platelet inhibiting treatment in coronary artery disease When investigating possible effects of platelet-inhibitingtreatment with Repeated...
  • 14
  • 521
  • 0
báo cáo hóa học:

báo cáo hóa học: " Improvement in health-related quality of life after therapy with omeprazole in patients with coronary artery disease and recurrent angina-like chest pain. A double-blind, placebo-controlled trial of the SF-36 survey" ppt

Hóa học - Dầu khí

... [3,4].Patients with coronary artery disease (CAD) and refrac-tory or recurrent retrosternal symptoms have a reductionin life expectancy and HRQL compared to patients w ithstable coronary artery disease ... Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med 2010, 363:1909-17.43. Juurlink DN: Clopidogrel with or without omeprazole in coronary disease. N Engl J Med 2011, 364:681-2.44. ... moreeffectively than the placebo.List of abbreviationsHRQL: health-related quality of life; CAD: coronary artery disease; GER:gastroesophageal reflux; PPI: proton pump inhibitors; HRQLRAD: Quality ofLife...
  • 9
  • 483
  • 0
Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease pot

Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease pot

Sức khỏe giới tính

... atherosclerosis. What about cardiovascular disease? The immu-nomodulatory effects of statins in various autoim-mune diseases apply equally well to cardiovascu-lar disease, in which surprisingly similar ... patients with heart fail-ure and left ventricular systolic dysfunction attri-buted to coronary artery disease. The study, called the Controlled Rosuvastatin Multinational Trial in Heart Failure ... reconciled with the existing randomized trials of statins in patients with es-tablished coronary artery disease? First, statins as a class may not be efficacious in patients with ischemic left...
  • 18
  • 315
  • 0
Angiotensin-Converting– Enzyme Inhibition in Stable Coronary Artery Disease potx

Angiotensin-Converting– Enzyme Inhibition in Stable Coronary Artery Disease potx

Sức khỏe giới tính

... 56 Coronary disease on angiography 61 61Angina pectoris 70 71Percutaneous coronary intervention 42 41 Coronary- artery bypass grafting 38 40Percutaneous coronary intervention or coronary- artery ... withvascular disease who do not have overt heart failurereduces the risk of major atherosclerotic events. InHOPE, high-risk patients with vascular disease (in-cluding coronary artery disease) or diabetes ... of Cardiac Events with Perindopril inStable Coronary Artery Disease (EUROPA), 16 pa-tients with coronary or other vascular disease orwith diabetes and another cardiovascular risk fac-tor...
  • 15
  • 285
  • 0
Drug-Eluting Stents vs. Coronary-Artery Bypass Grafting in Multivessel Coronary Disease pot

Drug-Eluting Stents vs. Coronary-Artery Bypass Grafting in Multivessel Coronary Disease pot

Sức khỏe giới tính

... multivessel coronary artery disease are CABG 100Survival (%)95908500 3 6 9 12 1518MonthsCThree-Vessel Disease A Three-Vessel Disease B Two-Vessel Disease DTwo-Vessel Disease No. at ... of diseased vessels and by the presence or absence of disease in the proximal left anterior descending (LAD) coronary artery. Data from patients with two-vessel disease who had no LAD artery ... 96.3No. of diseased vessels (%)‡ <0.0013, with proximal LAD artery 51.5 11.83, without proximal LAD artery 18.4 13.12, with proximal LAD artery 20.0 26.12, without proximal LAD artery 10.1...
  • 16
  • 207
  • 0
Báo cáo y học:

Báo cáo y học: "Trace Elements, Heavy Metals and Vitamin Levels in Patients with Coronary Artery Diseas"

Y học thưởng thức

... stores and the risk of coronary heart disease. N Engl J Med. 1994; 330: 1119–1124. 19. Ascherio A, Willett WC, Rimm EB, et al. Blood donations and risk of coronary heart disease in men. Circulation. ... stores, dietary iron intake and coronary heart disease mortality. J In-tern Med. 1995; 238: 223-230. 21. Liao Y, Cooper RS, McGee DL. Iron status and coronary heart disease: negative findings from ... Masironi R. Trace elements and cardiovascular diseases. Bull World Health Organ. 1969; 40: 305–312. 28. Kromhout D. Blood lead and coronary heart disease risk among elderly men in Zutphen the...
  • 5
  • 527
  • 0

Xem thêm